GlobalData analyst Christie Wong said Produodopa’s nearest rival at the moment is Britannia Pharmaceuticals’ continuous subcutaneous infusion of apomorphine delivered using the Apo-go pump ...

Q4 2024 Earnings Call Transcript March 12, 2025 Operator: Greetings. And welcome to the KORU Medical Systems’ Fourth Quarter ...

Today, the majority of this large-volume subcutaneous market is made up ... syringes to load without interrupting their infusion. The pump will also offer enhanced mobility, ease of use, and ...

has become the first subcutaneous 24-hour continuous infusion of levodopa-based therapy for the treatment of motor fluctuations in advanced Parkinson's, delivered via a pump. Questions about the ...

The FDA approval of Alnylam’s Amvuttra sets up a three-way race with Pfizer and BridgeBio, which both market transthyretin ...

an infusion pump and manual push with a syringe. The belief is that the new self-administered subcutaneous treatment may offer several advantages, including high levels of patient satisfaction ...

Epoprostenol sodium is delivered by continuous i.v. administration using an ambulatory infusion pump through an indwelling ... entry vials for continuous subcutaneous administration at room ...

Otulfi was approved for both subcutaneous and intravenous formulations which ... In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius ...

We know that continuous infusion has shown the best efficacy with ... driven by limitations on the availability of pumps used to administer treprostinil injections subcutaneously.